Fulcrum Therapeutics
Price & Volume
Stats
See more52W Range | $2.31-$10.13 |
Market Cap | $342.9M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$52.7M |
Diluted EPS | -$1.18 |
News
See moreYahoo Finance • 4 days ago
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 14 days ago
Noteworthy Tuesday Option Activity: PII, FULC, OXY
Yahoo Finance • 14 days ago
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025
About
CEO | Mr. Alexander C. Sapir |
Address | 26 Landsdowne Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 45 |
